In-Vitro Generation of T-Cell Clones to Difluorophenylglyoxal: Implications for Understanding the Immunogenicity of MK-3207
Chemical Research in Toxicology · 17.08.2026 · 39 (8) · 1503-1507
DOI: 10.1021/acs.chemrestox.6c00294 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Research in Toxicology, online erschienen am 30.07.2026. Verfasst von Paul Thomson und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department Pharmacology and Therapeutics, University of Liverpool, LiverpoolL693GE, U.K. Hauptthemen laut MEDLINE: T-Lymphocytes. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Merck.
Abstract (Originalsprache)
MK-3207 was withdrawn from development because of drug-induced liver injury. Metabolic studies identified bioactivation to a protein-reactive 3,5-difluorophenylglyoxal (DFPG) intermediate. Although phenylglyoxal metabolites readily form protein adducts, their immunogenic potential has been poorly understood. We compared the immunogenicity of three DFPG isomers (3,5-, 2,4-, and 3,4-DFPG) using T-cell clones generated from treated healthy donor PBMCs. Reactive clones were detected against isomers with 3,5-DFPG inducing the strongest responses. Activation required antigen processing, and no cross-reactivity with MK-3207 was observed. These findings demonstrate the immunogenicity of 3,5-DFPG and show that structural differences among phenylglyoxal isomers influence T cell activation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department Pharmacology and Therapeutics, University of Liverpool, LiverpoolL693GE, U.K.
- Institute for Immunology and Infectious Diseases, Murdoch University, MurdochWA6150, Australia.
- Investigative Toxicology, Nonclinical Drug Safety, Merck & Co., West Point, Pennsylvania19486, United States.
ORCID-Profile: Paul Thomson, Jackie Shang, Xiaoli Meng, Sophie Grice, Yu Feng, Dean Naisbitt
Förderung
- Merck
Zitieren
APA
Thomson, P., Gibson, A., Shang, J., Meng, X., Saville, E., Grice, S., Ford, M., Feng, Y., Pearson, K., Oropallo, M., Gonzalez, R., Monroe, J., & Naisbitt, D. (2026). In-Vitro Generation of T-Cell Clones to Difluorophenylglyoxal: Implications for Understanding the Immunogenicity of MK-3207. Chemical Research in Toxicology, 39(8), 1503-1507. https://doi.org/10.1021/acs.chemrestox.6c00294
Vancouver
Thomson P, Gibson A, Shang J, Meng X, Saville E, Grice S, et al. In-Vitro Generation of T-Cell Clones to Difluorophenylglyoxal: Implications for Understanding the Immunogenicity of MK-3207. Chemical Research in Toxicology. 2026;39(8):1503-1507. doi:10.1021/acs.chemrestox.6c00294
BibTeX
@article{Thomson2026,
author = {Thomson, Paul and Gibson, Andrew and Shang, Jackie and Meng, Xiaoli and Saville, Eleanor and Grice, Sophie and Ford, Megan and Feng, Yu and Pearson, Kara and Oropallo, Michael and Gonzalez, Raymond and Monroe, James and Naisbitt, Dean},
title = {In-Vitro Generation of T-Cell Clones to Difluorophenylglyoxal: Implications for Understanding the Immunogenicity of MK-3207},
journal = {Chemical Research in Toxicology},
year = {2026},
volume = {39},
number = {8},
pages = {1503--1507},
doi = {10.1021/acs.chemrestox.6c00294}
}
EUVIMED